Optimization of Sentinel Lymph Node Imaging Methodology Using Anionic Liposome and Hyaluronidase.
liposome
phosphatidylserine
sentinel lymph node
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
14 Sep 2021
14 Sep 2021
Historique:
received:
18
08
2021
revised:
09
09
2021
accepted:
10
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
The sentinel lymph node (SLN) is the first lymph node into which lymphatic fluid from tumor tissues flows. The development of a highly sensitive probe for detecting SLNs is desired for the lymph node dissection through intraoperative biopsy. We have previously shown that anionic liposomes tend to accumulate in lymph nodes and that macrophage uptake of liposomes contributes to their accumulation. In the present study, we found that among anionic lipids, phosphatidylserine (PS)-containing liposomes were substantially taken up by macrophages. We identified a new lipid composition to improve the SNL-selectivity of liposome accumulation based on Design-of-Experiment. The optimized PS-containing particles were more selectively accumulate to SLN lymph nodes than existing imaging agents indocyanine green. These results indicate the effectiveness of PS-containing anionic particles in SLN imaging.
Identifiants
pubmed: 34575540
pii: pharmaceutics13091462
doi: 10.3390/pharmaceutics13091462
pmc: PMC8465215
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Core Research for Evolutional Science and Technology
ID : PMJCR17H1
Organisme : Japan Society for the Promotion of Science
ID : 20K20195
Organisme : Yasuda Memorial Medical Foundation
ID : Not applicable
Organisme : Terumo Foundation for Life Sciences and Arts
ID : Not appliacble
Références
Ann Surg Oncol. 2013 Jul;20(7):2213-8
pubmed: 23429938
J Res Natl Inst Stand Technol. 1991 Sep-Oct;96(5):577-591
pubmed: 28184132
Breast Care (Basel). 2018 Oct;13(5):349-353
pubmed: 30498420
Surg Today. 2020 Nov;50(11):1332-1342
pubmed: 31664525
Nat Rev Drug Discov. 2015 Nov;14(11):781-803
pubmed: 26471369
Cancers (Basel). 2019 Dec 20;12(1):
pubmed: 31877623
Ann Surg. 1995 Sep;222(3):394-9; discussion 399-401
pubmed: 7677468
J Clin Oncol. 1997 Jun;15(6):2345-50
pubmed: 9196149
Nat Rev Immunol. 2020 Sep;20(9):566-578
pubmed: 32094869
Adv Healthc Mater. 2012 Sep;1(5):582-9
pubmed: 23184793
Future Oncol. 2018 Jan;14(1):13-22
pubmed: 29235360
Nat Immunol. 2009 Jul;10(7):786-93
pubmed: 19503106
Br J Cancer. 2005 Jul 11;93(1):81-8
pubmed: 15942637
Sci Transl Med. 2021 Mar 17;13(585):
pubmed: 33731430
Mol Ther. 2021 Jan 6;29(1):225-235
pubmed: 32966771
Ann Surg. 1994 Sep;220(3):391-8; discussion 398-401
pubmed: 8092905
Nano Lett. 2016 Apr 13;16(4):2512-21
pubmed: 27022664
Pharm Nanotechnol. 2018;6(4):264-275
pubmed: 30394227
Surg Oncol Clin N Am. 2015 Apr;24(2):249-60
pubmed: 25769710
Nature. 2007 Nov 15;450(7168):435-9
pubmed: 17960135
Front Immunol. 2019 May 03;10:953
pubmed: 31130951
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):E1463-72
pubmed: 24706780
J Biol Chem. 2000 Jun 23;275(25):19139-45
pubmed: 10779521
Proc Natl Acad Sci U S A. 2010 May 11;107(19):8706-11
pubmed: 20368430
Sci Rep. 2018 Apr 12;8(1):5921
pubmed: 29651026
Recent Results Cancer Res. 2001;158:137-46
pubmed: 11092041
Small. 2016 Sep;12(35):4894-4901
pubmed: 27439987
Int J Pharm. 2021 Aug 10;605:120772
pubmed: 34098051
CA Cancer J Clin. 2000 Sep-Oct;50(5):279-91
pubmed: 11075238
Science. 2016 Apr 8;352(6282):242-6
pubmed: 26989197
Langmuir. 2021 Jan 26;37(3):1120-1128
pubmed: 33439022
Clin Breast Cancer. 2016 Jun;16(3):155-65
pubmed: 26952594
J Pharm Sci. 2017 Jan;106(1):168-175
pubmed: 27649887